2016
DOI: 10.26442/2075-1753_2016.5.23-29
|View full text |Cite
|
Sign up to set email alerts
|

Dihydropyridine calcium channel blockers in the treatment of arterial hypertension: efficacy and safety of felodipine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Due to the lack of clear scientifically grounded recommendations on medication-assisted treatment of various types of AH, doctors in practical healthcare are forced to administer treatment intuitively, based on their personal experience. Patients do not take medicine on regular basis, therefore their ABP can hardly be controlled and remains elevated 1,2,3,4 . Therefore, the search for an optimal individualized approach to the treatment of AH patients with hypotensive drugs is considered to be an urgent issue.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to the lack of clear scientifically grounded recommendations on medication-assisted treatment of various types of AH, doctors in practical healthcare are forced to administer treatment intuitively, based on their personal experience. Patients do not take medicine on regular basis, therefore their ABP can hardly be controlled and remains elevated 1,2,3,4 . Therefore, the search for an optimal individualized approach to the treatment of AH patients with hypotensive drugs is considered to be an urgent issue.…”
Section: Introductionmentioning
confidence: 99%
“…At present, a great selection of hypotensive drugs is available with the drugs of calcium channel blocker class being of particular interest 4,9,10,11 . A number of research works demonstrate the ability of some drugs of this class to prevent the development of cardiovascular complications 1,12,13,3 . At the present time, extended-release diltiazem is widely used and highly researched from the perspective of evidence-based medicine 13 .…”
Section: Introductionmentioning
confidence: 99%